CD19 (Inebilizumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7607793

This anti-CD19 (Inebilizumab Biosimilar) antibody is a Humanized Monoclonal antibody detecting CD19 (Inebilizumab Biosimilar) in ELISA and FACS. Suitable for Human.

Quick Overview for CD19 (Inebilizumab Biosimilar) antibody (Biotin) (ABIN7607793)

Target: CD19 (Inebilizumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD19 (Inebilizumab Biosimilar) antibody is conjugated to Biotin

Application: ELISA, Flow Cytometry (FACS)

Product Details anti-CD19 (Inebilizumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-CD19 (inebilizumab biosimilar)mAb

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Target Details for CD19 (Inebilizumab Biosimilar)

Target: CD19 (Inebilizumab Biosimilar)

Alternative Name: inebilizumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CD19,4,VID3,GC12802
Synonyms Antibody:MEDI-551,Medi-551